Npwt denied as non-formulary by Aetna?

Aetna's specific coverage criteria for npwt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies NPWT as Non-Formulary

Negative Pressure Wound Therapy (NPWT) is primarily a durable medical equipment (DME) benefit rather than a pharmacy benefit — however, Aetna may issue a non-formulary or non-covered-benefit denial when a specific NPWT device, disposable system, or single-use NPWT product is not listed on Aetna's DME fee schedule or approved product list, or when the claim is filed under the pharmacy benefit for a disposable NPWT product that requires a separate formulary exception. The pathway forward depends on which benefit category applies.

## Why This Denial Is Appealable

Aetna is required to process NPWT claims under the correct benefit category for the product type. If the denial reflects a product-list or formulary categorization issue rather than a clinical one, it is correctable through a formulary exception or non-formulary exception request. If the product is clinically equivalent to a listed product but was prescribed for a specific clinical reason (e.g., single-use NPWT for home use vs. traditional negative-pressure unit), the prescribing clinician can document why the specific product is medically necessary. A non-formulary denial does not mean NPWT itself is not covered — it means the specific product requires additional justification.

## Federal Appeal Framework

• Non-formulary exception request: File before or alongside the internal appeal. The prescriber documents why the specific NPWT product is medically necessary over any listed alternative.
• Internal appeal: Under ERISA §503 and ACA §2719, a non-formulary denial is an adverse benefit determination subject to full-and-fair internal review.
• External review: After exhausting internal appeal, binding IRO review is available under ACA §2719. File within the four-month external-review window.
• Expedited review: If the patient's wound is acutely deteriorating and access to the specific NPWT product cannot be delayed, request expedited review.

## Concrete Appeal Steps and Timeline

1. Identify from the denial notice exactly which product (by HCPCS code or brand name) Aetna deemed non-formulary or non-covered, and which products (if any) Aetna identifies as covered alternatives. 2. Consult with the prescribing clinician on whether a covered alternative is clinically appropriate — or whether the prescribed product has specific clinical features that are necessary for this patient. 3. File a non-formulary exception request with a prescriber letter explaining the clinical rationale for the specific product. 4. If the exception is denied, file a formal internal appeal. 5. Escalate to external review if the internal appeal fails.

## Documentation to Gather

• Product comparison: A list of Aetna's covered NPWT products (from the denial letter, Aetna's DME fee schedule, or formulary) alongside the prescribed product, with a clinician statement addressing clinical differences.
• Clinical rationale for prescribed product: If single-use NPWT is prescribed for home use, document why a traditional rental unit is clinically impractical or inferior for this patient's wound type, setting, or functional status.
• Wound care records: Wound type, size, drainage, and prior treatment history confirming that NPWT is clinically indicated at all (this supports the broader medical-necessity argument alongside the formulary exception).
• Prescriber medical-necessity letter: Identifies the specific product, explains the clinical need for it over covered alternatives, and confirms the FDA clearance of the product for the wound type at issue.

## Criteria-Mapping Structure

Obtain Aetna's non-formulary exception criteria from the denial letter or Aetna's published DME/formulary exception policy. Map each criterion:

| Aetna Exception Criterion | Supporting Evidence | |---|---| | [Copy criterion verbatim from Aetna's policy or denial notice] | [Product comparison, clinician note, or wound record with date and source] |

A tightly documented exception request — paired with a clear clinical argument for why the specific product is necessary — is the most effective approach for non-formulary NPWT denials.